Cargando…
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
Convalescent plasma therapy (CPT) has gained significant attention since the onset of the coronavirus disease 2019 (COVID-19) pandemic. However, clinical trials designed to study the efficacy of CPT based on antibody concentrations were inconclusive. Lymphatic transport is at the interplay between t...
Autores principales: | Amri, Nada, Bégin, Rémi, Tessier, Nolwenn, Vachon, Laurent, Villeneuve, Louis, Bégin, Philippe, Bazin, Renée, Loubaki, Lionel, Martel, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948637/ https://www.ncbi.nlm.nih.gov/pubmed/35337162 http://dx.doi.org/10.3390/ph15030365 |
Ejemplares similares
-
Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy
por: Amri, Nada, et al.
Publicado: (2022) -
Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine
por: Tessier, Nolwenn, et al.
Publicado: (2021) -
Downregulation of low-density lipoprotein receptor mRNA in lymphatic endothelial cells impairs lymphatic function through changes in intracellular lipids
por: Vachon, Laurent, et al.
Publicado: (2022) -
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020) -
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)